NIH-funded research Fellowship grant

Understanding how a specific protein affects tuberculosis bacteria in immune cell clusters

Official title: The Sigma factor SigE's role in mycobacterial granulomas

Funded at Duke University · NIH-11076333 · Data updated 2026-11-12

This study is looking at how a specific part of the tuberculosis bacteria helps it survive in the immune system's protective clusters, which could lead to new treatments for patients with tuberculosis.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startApril 1, 2024
Project endMarch 31, 2027
Funding year2025
Award (this year)$41,986
NIH project number5F31AI179076-02
Project IDNIH-11076333 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who are affected by tuberculosis or are at risk of infection.

Less likely to help

Patients with non-tuberculosis related infections or those who are not adults may not receive any benefit from this research.

What this research studies

This research investigates the role of the sigma factor SigE in the survival of Mycobacterium tuberculosis within immune cell clusters known as granulomas. By using a zebrafish model, the study aims to uncover how specific components of the bacterial cell envelope interact with the host immune response. The research will focus on how these interactions influence the bacteria's ability to persist in the granuloma, which is crucial for developing new therapeutic strategies against tuberculosis. Patients may benefit from insights gained that could lead to novel treatments targeting these bacterial components.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that more effectively target and eliminate tuberculosis bacteria from the body.

How similar studies have gone: Previous research has shown promise in targeting bacterial components in similar contexts, indicating potential for success in this novel approach.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Menon, Aruna Rajendran — Duke University
  • Study coordinator: Menon, Aruna Rajendran

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.